Overview

Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction

Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the analgesic efficacy of single and multiple doses of a new fixed dose combination of nefopam hydrochloride 30 mg and paracetamol 500mg taken orally in comparison to each single component.
Phase:
Phase 3
Details
Lead Sponsor:
Unither Pharmaceuticals, France
Collaborator:
EXCELYA Bordeaux
Treatments:
Acetaminophen
Nefopam